JFL Life Sciences P/E Ratio
Current P/E Ratio
4.64
Low Valuation
Very Low - Potentially undervalued or facing challenges
JFL Life Sciences (JFLLIFE) P/E ratio is 4.64 (Low), EPS (TTM) ₹1.94, current price ₹ on None — Very Low - Potentially undervalued or facing challenges. See JFLLIFE price book multiple to compare market price against book value per share.
Current Valuation Metrics
P/E Ratio
4.64
Current Price
₹
EPS (TTM)
₹1.94
Exchange
None
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
55.52
Sector Median
31.4
Sector Rank
#4 of 194
Sector Percentile
2.1%
JFLLIFE P/E Ratio — Valuation Signal & Historical Context
JFL Life Sciences P/E 4.64 — signal: Undervalued. Read JFLLIFE dividend track record for the complete payout history and dividend yield track record.
- Stock appears undervalued with PE of 4.64, suggesting potential buying opportunity
- Trading at discount to sector average PE of 55.52
JFLLIFE vs Healthcare Peers — P/E Ratio Comparison
JFL Life Sciences P/E 4.64 vs Healthcare average 55.52, median 31.4 — range 2.86–987.08.
Sector Average
55.52
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
987.08
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.84 | ₹68 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |
| Par Drugs & Chemical | PAR | 8.43 | ₹111 | Low |